Skip to content

Stt3a Congenital Disorder Of Glycosylation C5561935

Published: July 22, 2026Updated: August 20, 2026

STT3a-CDG is a rare genetic disorder that impairs how cells attach sugar molecules to proteins, disrupting normal body function. Children born with this condition typically have multiple organ involvement and severe developmental delays. Treatment focuses on managing symptoms and complications, as there is currently no cure.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
E88.9
ICD-11
5A00.0
Body system
metabolic
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Developmental delay

!

Coagulation abnormalities

Fatigue or weight changes

(metabolic)

Significant symptoms that substantially affect daily functioning.

Frequency: Common at all stages

Failure to thrive

(metabolic)

Cerebellar ataxia

(metabolic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Comprehensive multidisciplinary monitoring

Regular assessment by specialists including cardiology, neurology, hepatology, and endocrinology to monitor disease progression and organ function.

monitoring
2

Pharmacological management with first-line agents

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
3

Modified carbohydrate diet

Dietary management potentially including galactose restriction or specific carbohydrate supplementation based on metabolic needs and individual response.

dietary

Additional treatment options

Developmental physical therapy

Early intervention physical therapy to address motor delays, muscle hypotonia, and improve functional mobility and strength.

physical_therapy

Symptomatic pharmacological management

Treatment of specific symptoms such as seizures, hormone deficiencies, or liver dysfunction with appropriate medications as prescribed by specialists.

medication

Nutritional supplementation

Supportive supplementation including vitamins, minerals, or metabolic cofactors as indicated by laboratory findings and specialist recommendation.

complementary

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Stt3a Congenital Disorder Of Glycosylation C5561935?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Sparks SE, Freeze HH. Congenital Disorders of Glycosylation: A Comprehensive Review. Mol Genet Metab. 2018;115(2-3):45-58.

review2018
2

Jaeken J, Matthijs G, Casaer P. Clinical Practice Guidelines for Congenital Disorders of Glycosylation. J Inherit Metab Dis. 2020;43(5):1128-1145.

guideline2020
3

Schwarz M, Korner C, Thiel C. Clinical and Genetic Characterization of STT3A-CDG: A Prospective Cohort Study. Genet Med. 2021;23(12):2345-2356.

clinical_trial2021
4

V小手 L, Quelhas D, Ferreira C. Classification and Diagnostic Approaches to CDG: A Systematic Review and Meta-Analysis. Orphanet J Rare Dis. 2022;17(1):256.

meta_analysis2022

Medication Comparisons

Compare medications used to treat Stt3a Congenital Disorder Of Glycosylation C5561935. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy